📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Treatment-induced hypoxia attenuates enzalutamide response and promotes resistance in pre-clinical models of prostate cancer (2017)

First Author: Maxwell P

Attributed to: The central importance of CXCL8 signaling to inflammatory-based tumour initiation and invasive prostate carcinoma. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx361.028

Publication URI: http://dx.doi.org/10.1093/annonc/mdx361.028

Type: Journal Article/Review

Parent Publication: Annals of Oncology